Prelude Capital Management’s Sanaby Health Acquisition Corp. I Class A Common Stock SANB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-53,900
Closed -$546K 1918
2022
Q3
$546K Buy
+53,900
New +$544K 0.02% 619

Prelude Capital Management's SANB Position: Q4 2022 in Review

Prelude Capital Management sold out of Sanaby Health Acquisition Corp. I Class A Common Stock (SANB) in Q4 2022, closing a stake of 53,900 shares — an estimated $546K sold.

Prelude Capital Management first reported a position in SANB in Q3 2022 and held it in 1 quarter. The position peaked at $546K in Q3 2022. 0 funds tracked by Wall St. Rank hold SANB as of Q4 2022.

  • Prelude Capital Management reported no remaining Sanaby Health Acquisition Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Prelude Capital Management sold 53,900 Sanaby Health Acquisition Corp. I Class A Common Stock shares in Q4 2022, an estimated $546K.
  • Prelude Capital Management first reported a position in Sanaby Health Acquisition Corp. I Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • Prelude Capital Management's Sanaby Health Acquisition Corp. I Class A Common Stock position peaked at $546K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Sanaby Health Acquisition Corp. I Class A Common Stock as of Q4 2022.

Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.